Board of Directors
Jennifer Cook has served as a member of our board of directors since December 2019. Cook has more than 30 years of experience in the global biotech and pharmaceutical industry and brings global commercial expertise to the board. She served as Chief Executive Officer of GRAIL, Inc. from January 2018 to June 2019. She led Roche’s European commercial business from August 2013 to December 2016 and was Roche Pharma’s Global Head of Clinical Operations throughout 2017. From 2010 to 2013 she oversaw Genentech, Inc.’s U.S. Immunology and Ophthalmology Business Unit. She currently serves on the board of directors at Denali Therapeutics, a position she has held since November 2018. Cook was honored as the Woman of the Year by the Healthcare Businesswomen's Association in 2016 and was named one of the Most Influential Women in Business by The San Francisco Business Times in 2012. Cook holds a B.A. in human biology and an M.S. in biology from Stanford University. She has an M.B.A. from the Haas School of Business at the University of California, Berkeley.